Global Adipose Stem Cells (ASCs) Market Professional Survey Report 2016

June 2016 | 110 pages | ID: GA66C666B2CEN
QYResearch

Abstracts

This report mainly covers the following

Product types including

• Medical Application
• Cosmetic Application
• Others

The segment applications including

• Hematopoietic stem cell transplantation
• Tissue repair damage
• Autoimmune diseases
• As gene therapy vectors.

Segment regions including (the separated region report can also be offered)

• North America
• Europe
• Japan
• China
• Southeast Asia
• India

The players list (Partly, Players you are interested in can also be added)

• ScienCell Research Laboratories
• PromoCell
• Athersys
• Axiogenesis
• Beike Biotechnology
• BioE
• Bio-Master
• BioTime
• Cellerant Therapeutics
• Cellartis
• California Stem Cell
• BrainStorm Cell Therapeutics
• EMD Millipore
• Epistem
• Geron
• Histostem
• LifeCell
• Minerva Biotechnologies
• ReNeuron Group

With 19 top producers.

Data including (both global and regions): Market Size (both volume - Unit and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Unit, Cost, Gross margin etc.

More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!

Contents

1 INDUSTRY OVERVIEW OF ADIPOSE STEM CELLS (ASCS)

1.1 Definition and Specifications of Adipose Stem Cells (ASCs)
  1.1.1 Definition of Adipose Stem Cells (ASCs)
  1.1.2 Specifications of Adipose Stem Cells (ASCs)
1.2 Classification of Adipose Stem Cells (ASCs)
  1.2.1 Medical Application
  1.2.2 Cosmetic Application
  1.2.3 Others
1.3 Applications of Adipose Stem Cells (ASCs)
  1.3.1 Hematopoietic stem cell transplantation
  1.3.2 Tissue repair damage
  1.3.3 Autoimmune diseases
  1.3.4 As gene therapy vectors.
1.4 Industry Chain Structure of Adipose Stem Cells (ASCs)
1.5 Industry Overview and Major Regions Status of Adipose Stem Cells (ASCs)
  1.5.1 Industry Overview of Adipose Stem Cells (ASCs)
  1.5.2 Global Major Regions Status of Adipose Stem Cells (ASCs)
1.6 Industry Policy Analysis of Adipose Stem Cells (ASCs)
1.7 Industry News Analysis of Adipose Stem Cells (ASCs)

2 MANUFACTURING COST STRUCTURE ANALYSIS OF ADIPOSE STEM CELLS (ASCS)

2.1 Raw Material Suppliers and Price Analysis of Adipose Stem Cells (ASCs)
2.2 Equipment Suppliers and Price Analysis of Adipose Stem Cells (ASCs)
2.3 Labor Cost Analysis of Adipose Stem Cells (ASCs)
2.4 Other Costs Analysis of Adipose Stem Cells (ASCs)
2.5 Manufacturing Cost Structure Analysis of Adipose Stem Cells (ASCs)
2.6 Manufacturing Process Analysis of Adipose Stem Cells (ASCs)

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF ADIPOSE STEM CELLS (ASCS)

3.1 Capacity and Commercial Production Date of Global Adipose Stem Cells (ASCs) Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Adipose Stem Cells (ASCs) Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Adipose Stem Cells (ASCs) Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Adipose Stem Cells (ASCs) Major Manufacturers in 2015

4 GLOBAL ADIPOSE STEM CELLS (ASCS) OVERALL MARKET OVERVIEW

4.1 2011-2016E Overall Market Analysis
  4.2.1 2011-2015 Global Adipose Stem Cells (ASCs) Capacity and Growth Rate Analysis
  4.2.2 2015 Adipose Stem Cells (ASCs) Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2011-2015 Global Adipose Stem Cells (ASCs) Sales and Growth Rate Analysis
  4.3.2 2015 Adipose Stem Cells (ASCs) Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2011-2015 Global Adipose Stem Cells (ASCs) Sales Price
  4.4.2 2015 Adipose Stem Cells (ASCs) Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
  4.5.1 2011-2015 Global Adipose Stem Cells (ASCs) Gross Margin
  4.5.2 2015 Adipose Stem Cells (ASCs) Gross Margin Analysis (Company Segment)

5 ADIPOSE STEM CELLS (ASCS) REGIONAL MARKET ANALYSIS

5.1 North America Adipose Stem Cells (ASCs) Market Analysis
  5.1.1 North America Adipose Stem Cells (ASCs) Market Overview
  5.1.2 North America 2011-2016E Adipose Stem Cells (ASCs) Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2011-2016E Adipose Stem Cells (ASCs) Sales Price Analysis
  5.1.4 North America 2015 Adipose Stem Cells (ASCs) Market Share Analysis
5.2 Europe Adipose Stem Cells (ASCs) Market Analysis
  5.2.1 Europe Adipose Stem Cells (ASCs) Market Overview
  5.2.2 Europe 2011-2016E Adipose Stem Cells (ASCs) Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 Europe 2011-2016E Adipose Stem Cells (ASCs) Sales Price Analysis
  5.2.4 Europe 2015 Adipose Stem Cells (ASCs) Market Share Analysis
5.3 Japan Adipose Stem Cells (ASCs) Market Analysis
  5.3.1 Japan Adipose Stem Cells (ASCs) Market Overview
  5.3.2 Japan 2011-2016E Adipose Stem Cells (ASCs) Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Japan 2011-2016E Adipose Stem Cells (ASCs) Sales Price Analysis
  5.3.4 Japan 2015 Adipose Stem Cells (ASCs) Market Share Analysis
5.4 China Adipose Stem Cells (ASCs) Market Analysis
  5.4.1 China Adipose Stem Cells (ASCs) Market Overview
  5.4.2 China 2011-2016E Adipose Stem Cells (ASCs) Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 China 2011-2016E Adipose Stem Cells (ASCs) Sales Price Analysis
  5.4.4 China 2015 Adipose Stem Cells (ASCs) Market Share Analysis
5.5 Southeast Asia Adipose Stem Cells (ASCs) Market Analysis
  5.5.1 Southeast Asia Adipose Stem Cells (ASCs) Market Overview
  5.5.2 Southeast Asia 2011-2016E Adipose Stem Cells (ASCs) Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Southeast Asia 2011-2016E Adipose Stem Cells (ASCs) Sales Price Analysis
  5.5.4 Southeast Asia 2015 Adipose Stem Cells (ASCs) Market Share Analysis
5.6 India Adipose Stem Cells (ASCs) Market Analysis
  5.6.1 India Adipose Stem Cells (ASCs) Market Overview
  5.6.2 India 2011-2016E Adipose Stem Cells (ASCs) Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2011-2016E Adipose Stem Cells (ASCs) Sales Price Analysis
  5.6.4 India 2015 Adipose Stem Cells (ASCs) Market Share Analysis

6 GLOBAL 2011-2016E ADIPOSE STEM CELLS (ASCS) SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2011-2016E Adipose Stem Cells (ASCs) Sales by Type
6.2 Different Types Adipose Stem Cells (ASCs) Product Interview Price Analysis
6.3 Different Types Adipose Stem Cells (ASCs) Product Driving Factors Analysis
  6.3.1 Medical Application Adipose Stem Cells (ASCs) Growth Driving Factor Analysis
  6.3.2 Cosmetic Application Adipose Stem Cells (ASCs) Growth Driving Factor Analysis
  6.3.3 Others Adipose Stem Cells (ASCs) Growth Driving Factor Analysis

7 GLOBAL 2011-2016E ADIPOSE STEM CELLS (ASCS) SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
  7.3.1 Hematopoietic stem cell transplantation Adipose Stem Cells (ASCs) Growth Driving Factor Analysis
  7.3.2 Tissue repair damage Adipose Stem Cells (ASCs) Growth Driving Factor Analysis
  7.3.3 Autoimmune diseases Adipose Stem Cells (ASCs) Growth Driving Factor Analysis
  7.3.4 As gene therapy vectors. Adipose Stem Cells (ASCs) Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF ADIPOSE STEM CELLS (ASCS)

8.1 ScienCell Research Laboratories
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
  8.1.3 ScienCell Research Laboratories 2015 Adipose Stem Cells (ASCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 ScienCell Research Laboratories 2015 Adipose Stem Cells (ASCs) Business Region Distribution Analysis
8.2 PromoCell
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
  8.2.3 PromoCell 2015 Adipose Stem Cells (ASCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 PromoCell 2015 Adipose Stem Cells (ASCs) Business Region Distribution Analysis
8.3 Athersys
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
  8.3.3 Athersys 2015 Adipose Stem Cells (ASCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Athersys 2015 Adipose Stem Cells (ASCs) Business Region Distribution Analysis
8.4 Axiogenesis
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
  8.4.3 Axiogenesis 2015 Adipose Stem Cells (ASCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Axiogenesis 2015 Adipose Stem Cells (ASCs) Business Region Distribution Analysis
8.5 Beike Biotechnology
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
  8.5.3 Beike Biotechnology 2015 Adipose Stem Cells (ASCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Beike Biotechnology 2015 Adipose Stem Cells (ASCs) Business Region Distribution Analysis
8.6 BioE
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
  8.6.3 BioE 2015 Adipose Stem Cells (ASCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 BioE 2015 Adipose Stem Cells (ASCs) Business Region Distribution Analysis
8.7 Bio-Master
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
  8.7.3 Bio-Master 2015 Adipose Stem Cells (ASCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Bio-Master 2015 Adipose Stem Cells (ASCs) Business Region Distribution Analysis
8.8 BioTime
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
  8.8.3 BioTime 2015 Adipose Stem Cells (ASCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 BioTime 2015 Adipose Stem Cells (ASCs) Business Region Distribution Analysis
8.9 Cellerant Therapeutics
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
  8.9.3 Cellerant Therapeutics 2015 Adipose Stem Cells (ASCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Cellerant Therapeutics 2015 Adipose Stem Cells (ASCs) Business Region Distribution Analysis
8.10 Cellartis
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
  8.10.3 Cellartis 2015 Adipose Stem Cells (ASCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Cellartis 2015 Adipose Stem Cells (ASCs) Business Region Distribution Analysis
8.11 California Stem Cell
  8.11.1 Company Profile
  8.11.2 Product Picture and Specifications
  8.11.3 California Stem Cell 2015 Adipose Stem Cells (ASCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.11.4 California Stem Cell 2015 Adipose Stem Cells (ASCs) Business Region Distribution Analysis
8.12 BrainStorm Cell Therapeutics
  8.12.1 Company Profile
  8.12.2 Product Picture and Specifications
  8.12.3 BrainStorm Cell Therapeutics 2015 Adipose Stem Cells (ASCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.12.4 BrainStorm Cell Therapeutics 2015 Adipose Stem Cells (ASCs) Business Region Distribution Analysis
8.13 EMD Millipore
  8.13.1 Company Profile
  8.13.2 Product Picture and Specifications
  8.13.3 EMD Millipore 2015 Adipose Stem Cells (ASCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.13.4 EMD Millipore 2015 Adipose Stem Cells (ASCs) Business Region Distribution Analysis
8.14 Epistem
  8.14.1 Company Profile
  8.14.2 Product Picture and Specifications
  8.14.3 Epistem 2015 Adipose Stem Cells (ASCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.14.4 Epistem 2015 Adipose Stem Cells (ASCs) Business Region Distribution Analysis
8.15 Geron
  8.15.1 Company Profile
  8.15.2 Product Picture and Specifications
  8.15.3 Geron 2015 Adipose Stem Cells (ASCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.15.4 Geron 2015 Adipose Stem Cells (ASCs) Business Region Distribution Analysis
8.16 Histostem
  8.16.1 Company Profile
  8.16.2 Product Picture and Specifications
  8.16.3 Histostem 2015 Adipose Stem Cells (ASCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.16.4 Histostem 2015 Adipose Stem Cells (ASCs) Business Region Distribution Analysis
8.17 LifeCell
  8.17.1 Company Profile
  8.17.2 Product Picture and Specifications
  8.17.3 LifeCell 2015 Adipose Stem Cells (ASCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.17.4 LifeCell 2015 Adipose Stem Cells (ASCs) Business Region Distribution Analysis
8.18 Minerva Biotechnologies
  8.18.1 Company Profile
  8.18.2 Product Picture and Specifications
  8.18.3 Minerva Biotechnologies 2015 Adipose Stem Cells (ASCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.18.4 Minerva Biotechnologies 2015 Adipose Stem Cells (ASCs) Business Region Distribution Analysis
8.19 ReNeuron Group
  8.19.1 Company Profile
  8.19.2 Product Picture and Specifications
  8.19.3 ReNeuron Group 2015 Adipose Stem Cells (ASCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.19.4 ReNeuron Group 2015 Adipose Stem Cells (ASCs) Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF MARKET

9.1 Global Market Trend Analysis
  9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
  9.1.2 Global 2016-2021 Sales Price Forecast
  9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
  9.2.1 North America 2016-2021 Adipose Stem Cells (ASCs) Consumption Forecast
  9.2.2 Europe 2016-2021 Adipose Stem Cells (ASCs) Consumption Forecast
  9.2.3 Japan 2016-2021 Adipose Stem Cells (ASCs) Consumption Forecast
  9.2.4 China 2016-2021 Adipose Stem Cells (ASCs) Consumption Forecast
  9.2.5 Southeast Asia 2016-2021 Adipose Stem Cells (ASCs) Consumption Forecast
  9.2.6 India 2016-2021 Adipose Stem Cells (ASCs) Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)

10 ADIPOSE STEM CELLS (ASCS) MARKETING MODEL ANALYSIS

10.1 Adipose Stem Cells (ASCs) Regional Marketing Model Analysis
10.2 Adipose Stem Cells (ASCs) International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Adipose Stem Cells (ASCs) by Regions
10.4 Adipose Stem Cells (ASCs) Supply Chain Analysis

11 CONSUMERS ANALYSIS OF ADIPOSE STEM CELLS (ASCS)

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS OF ADIPOSE STEM CELLS (ASCS)

12.1 New Project SWOT Analysis of Adipose Stem Cells (ASCs)
12.2 New Project Investment Feasibility Analysis of Adipose Stem Cells (ASCs)

13 CONCLUSION OF THE GLOBAL ADIPOSE STEM CELLS (ASCS) MARKET PROFESSIONAL SURVEY REPORT 2016